图书馆订阅: Guest
肿瘤形成评论综述™

每年出版 4 

ISSN 打印: 0893-9675

ISSN 在线: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Gain of Antitumor Functions and Induction of Differentiation in Cancer Stem Cells Contribute to Complete Cure and No Relapse

卷 15, 册 1-2, 2009, pp. 65-90
DOI: 10.1615/CritRevOncog.v15.i1-2.30
Get accessGet access

摘要

The progeny of the mutated cell is maintained in a self-renewing tissue stem cell and its immediate progeny or due to cellular components that display stem cell like properties known as cancer stem cells (CSCs) that grow into cancer. Failure to achieve complete and safe eradication of cancer is due to the presence of quiescent population of cancer stem cells. Understanding and interfering with the processes of transformation of normal stem cells into their malignant counterparts, their micro-environmental niche and the mechanisms responsible for therapeutic resistance in CSCs enhance the curative efficacy of clinical elimination of all tumor cells. Functional identification of the molecular targets of CSCs provides useful insights for characterization of their response to particular therapy protocols. This review also focuses on the potential implications of promising novel therapies in suppression of oncogenic pathways specific to CSCs including their self-renewal capacity, property of drug transportation, seeding and oxidative stress, activation of apoptosis through the gain of antitumor molecules, restoration of DNA repair mechanisms and differentiation therapy that allows the terminal differentiation of CSCs thereby depleting their pool, all contribute to long-term disease control and improved patient survival. Significant developments in the optimization of combinational CSC-targeted therapies would lead to the improved outcome with great difference thus substantiating its profound impact in disease free survival with no relapse.

对本文的引用
  1. Liu Enli, Du Xue, Ge Rui, Liang Taigang, Niu Qiao, Li Qingshan, Comparative toxicity and apoptosis induced by diorganotins in rat pheochromocytoma (PC12) cells, Food and Chemical Toxicology, 60, 2013. Crossref

  2. Garg Minal, MicroRNAs, stem cells and cancer stem cells, World Journal of Stem Cells, 4, 7, 2012. Crossref

  3. Grunewald Thomas GP, Herbst Saskia M, Heinze Jürgen, Burdach Stefan, Understanding tumor heterogeneity as functional compartments - superorganisms revisited, Journal of Translational Medicine, 9, 1, 2011. Crossref

  4. Shibuya Keita, Okada Masashi, Suzuki Shuhei, Seino Manabu, Seino Shizuka, Takeda Hiroyuki, Kitanaka Chifumi, Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells, Oncotarget, 6, 2, 2015. Crossref

  5. Murakami Shigekazu, Ninomiya Wataru, Sakamoto Erina, Shibata Tatsuhiro, Akiyama Hirotada, Tashiro Fumio, SRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell-Like Properties and Are Potential Differentiation Therapy Targets, Stem Cells, 33, 9, 2015. Crossref

  6. Bautista Wendy, Lipschitz Jeremy, McKay Andrew, Minuk Gerald Y., Cancer Stem Cells are Depolarized Relative to Normal Stem Cells Derived from Human Livers, Annals of Hepatology, 16, 2, 2017. Crossref

Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集 订购及政策 Begell House 联系我们 Language English 中文 Русский Português German French Spain